Study of step down from high dose of salmeterol/fluticasone propionate combination(SFC) with tiotropium to middle dose of SFC + ciclesonide(CIC) with tiotropium in well controlled asthmatic patients with COPD

Study of step down from high dose of salmeterol/fluticasone propionate combination(SFC) with tiotropium to middle dose of SFC + ciclesonide(CIC) with tiotropium in well controlled asthmatic patients with COPD - Study of step down from high dose SFC with tiotropium to middle dose SFC + CIC with tiotropium in well controlled asthmatic patients with COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005063

Enrollment

Registered

2011-02-10

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthmatic patients with COPD

Interventions

ciclesonide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)total or well controlled asthmatic patients with COPD treated with SFC(500ug/day) + tiotropium 2)ex-smoker 3)FEV1% < 70% 4)asthma control test score >= 20 5)no medication change for 12weeks

Exclusion criteria

Exclusion criteria: 1)asthma control test score < 20 2)infection with bacteria or fungus 3)pregnancy 4)current smoker 5)investigator decision

Design outcomes

Primary

Measure	Time frame
ACT score at three month and six month	—

Countries

Japan

Contacts

Public ContactKazuhisa Asai

Graduate school of Medicine, Osaka City University Department of Respiratory Medicine

kokyuki@med.osaka-cu.ac.jp06-6645-3916

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026